Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: Preliminary results and survival analysis

Peritoneal mesothelioma is a rare disease with poor prognosis. The present study reports single center experience with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy with oxaliplatin (HIPEC-OX) over an eight-year period.

Source: Surgical Oncology - January 7, 2015 Category: Surgery Authors: Julien Hubert, Eva Thiboutot, Pierre Dubé, Alexis-Simon Cloutier, Pierre Drolet, Lucas Sideris Tags: Review Source Type: research